×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: AMPK-Mitochondrial Quality Control Axis
mechanism
1,209 words
KG: ent-prot-60b92a1d
2026-04-01
kind:mechanism
section:mechanisms
state:published
Contents
AMPK-Mitochondrial Quality Control Axis
⚙
Mechanism Info
Name
AMPK-Mitochondrial Quality Control Axis
Summary
How AMPK regulates mitochondrial biogenesis, mitophagy, and quality control in neurodegeneration
Knowledge Graph
Related Hypotheses (30)
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.57
SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK
Score: 0.51
Perforant Path Presynaptic Terminal Protection Strategy
Score: 0.48
Digital Twin-Guided Metabolic Reprogramming
Score: 0.61
Circadian-Synchronized Proteostasis Enhancement
Score: 0.58
TFAM overexpression creates mitochondrial donor-recipient gr
Score: 0.47
Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro
Score: 0.49
Gut Barrier Permeability-α-Synuclein Axis Modulation
Score: 0.49
APOE-TREM2 Interaction Modulation
Score: 0.48
Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci
Score: 0.45
Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration
Score: 0.45
The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
Score: 0.40
TFEB-PGC1α Mitochondrial-Lysosomal Decoupling
Score: 0.40
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67
SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc
Score: 0.60
TFEB-Independent Autophagy Bypass
Score: 0.51
Conditional CRISPR Kill Switches for Aberrant Protein Cleara
Score: 0.45
Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromat
Score: 0.52
APOE-Dependent Autophagy Restoration
Score: 0.61
Purinergic Signaling Polarization Control
Score: 0.55
Senescent Cell Mitochondrial DNA Release
Score: 0.54
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.50
Autophagosome Maturation Checkpoint Control
Score: 0.49
Ancestry-Adapted Mitochondrial Rescue Therapy
Score: 0.45
Mitochondrial Transfer Pathway Enhancement
Score: 0.44
Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.43
CX43 hemichannel engineering enables size-selective mitochon
Score: 0.41
RAB27A-dependent extracellular vesicle engineering for mitoc
Score: 0.41
Mitochondrial RNA Granule Rescue Pathway
Score: 0.40
Show 25 more
Related Analyses (30)
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Show 25 more
Related Experiments (24)
iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90
AMPK knockdown validation experiment
exploratory · proposed · Score: 0.88
iPSC-NPC transplantation in ICH animal model
validation · proposed · Score: 0.85
Germfree mouse colonocyte energy metabolism analysis
validation · proposed · Score: 0.90
Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40
Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40
Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson'
clinical · proposed · Score: 0.40
Mechanism: Selective Vulnerability of Dopaminergic Neurons i
validation · proposed · Score: 0.40
Selective Vulnerability of Dopaminergic Neurons — Mechanism
validation · proposed · Score: 0.40
GLP-1 Agonist Neuroprotection Mechanism in PD
clinical · proposed · Score: 0.40
GLP-1 Agonist Responder Prediction Study — Precision Medicin
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial
clinical · proposed · Score: 0.40
Peroxisome Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40
Sirtuin Pathway Dysfunction Validation in Parkinson's Diseas
clinical · proposed · Score: 0.40
IRI-AKI mouse model with mtROS inhibition
validation · proposed · Score: 0.90
mtROS effects on TFAM and mtDNA in HK2 cells
exploratory · proposed · Score: 0.90
Gandouling protection against brain injury in Wilson's disea
validation · proposed · Score: 0.90
Proposed experiment from debate on Mitochondrial transfer be
falsification · proposed · Score: 0.40
Epigenetic Clocks in Neurodegeneration — Causal Drivers or P
validation · proposed · Score: 0.40
Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40
Biomarker-Guided Sequential Therapy Selection in Alzheimer's
clinical · proposed · Score: 0.40
Lifestyle Intervention Mechanisms in Alzheimer's Disease
validation · proposed · Score: 0.40
Selective Neuronal Vulnerability to Aging — Mapping Why Spec
validation · proposed · Score: 0.40
Show 19 more